Answers are grounded in this paper and cite their sources.
Both intraneuronal Aβ accumulation and extracellular Aβ deposition was demonstrated in 5xFAD mice and 3xTg mice with MOAB-2, an antibody that will help differentiate intracellular Aβ from APP. However, further investigation is required to determine whether a molecular mechanism links the presence of intraneuronal Aβ with neurotoxicity. As well, understanding the relevance of these observations to human AD patients is critical.
No takes yet. Share an insight, caveat, or question.
Youmans et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: